Oct 02, 2024 TEAM-NB’s interpretation of “Structured Dialogue” between Manufacturer and Notified Body, clarifies little By Alex Denoon Anna Hall TEAM-NB has published a new version (v5.0) of its Code of Conduct for Notified Bodies. While we don’t normally comment on this Code,...
Sep 23, 2024 2024 ABPI Code of Practice launched - orange is the new blue By Jamie Hatzel The ABPI and the Prescription Medicines Code of Practice Authority (PMCPA) have announced the release of the latest edition of the ABPI...
Sep 02, 2024 Abbott Diabetes Care Inc. v Sibio Technology Limited – an update By Gregory Bacon Aida Tohala This article was first published in Kluwer Blog [August, 2024]. Background In June 2024, we reported that in an application for...
Aug 19, 2024 CASGEVY: CRISPR/Cas9 gene therapy now available in England following NICE recommendation By Claire Smith Luca Cericola Vertex Pharmaceuticals announced a reimbursement agreement with NHS England for individuals 12 years or older with transfusion-dependent...
Aug 13, 2024 UK – Samsung Bioepis v. Janssen Biotech / ustekinumab By Sophie Britton This article was first published in EPLAW blog [August, 2024]. Patents Court finds Janssen Biotech’s patent, for the antibody ustekinumab...
Jul 25, 2024 Sanofi/Regeneron succeed against Amgen in first revocation decision issued by a Central Division of the UPC By Rebekka Thomas On 16 July 2024, the Munich Central Division published its decision in an action for revocation by a Sanofi group of companies (Sanofi)...
Jul 18, 2024 GDPR and scientific research in the UK: what are the new government's plans? By Mac Macmillan The King's Speech yesterday (which, for readers not in the UK, sets out the government's legislative plans) promises that the new Digital...
Jul 17, 2024 London's real estate landscape: How life sciences can drive change By Jessica Ebhomenye London's commercial real estate landscape is transforming, driven by the growing life sciences sector, which encompasses biotechnology,...
Jul 16, 2024 “This may hurt a bit…” – Moderna paves the way for COVID-19 vaccine damages claim against Pfizer and BioNTech in the UK By Charlie French This article was first published in Kluwer Patent Blog [July, 2024]. Moderna secured a double victory in the Patents Court last week (2...
Jul 10, 2024 UK – Moderna v. Pfizer & BioNTech By Ewan MacAulay James Johnston This article was first published in EPLAW Patent Blog, [July 2024]. On 2 July 2024, Mr Justice Meade handed down his decision in Moderna...
Jul 10, 2024 Challenges and opportunities for bio innovation: Views from the ON Helix 2024 conference By Adam Coughlin Luca Cericola Last week, Adam Coughlin and Luca Cericola from Bristows’ Commercial IP team attended ON Helix 2024, an annual conference hosted by One...
Jul 08, 2024 Labour's planning reforms for the life sciences sector By Tim Allen Hugo Kent-Egan “To ensure available lab space scales to meet the ambitions of our fast-growing research-intensive industries, not least the life...